Chronic Heart Failure
Conditions
Keywords
E health, Telemonitoring, Prevention, Heart Failure, Cordiva, Telecardiology Program, Remote Patient Management, Education
Brief summary
Targeted population: Patients with heart failure causing hospitalization during the last twelve months. Hypothesis: The number of all cause deaths and hospitalizations will be smaller for the Telecardiology group than for the reference group (standard follow-up care). An 18 months period of observation is required. Main goal: To compare the rate of all cause deaths and hospitalizations of patients with heart failure between the Telecardiology group and the reference group after 18 months of monitoring.
Detailed description
COMPARATIVE STUDY: Comparative study of patients with chronic heart failure, randomized ratio (1:1), with two study arms (telecardiology vs usual care). French multicenter study. The planned enrolment is 990 patients in a total period of 3.5 years. This study will involve an enrolment visit, managed by the recruiting investigator cardiologist, then four telephone contacts by Clinical Studies Technicians (CST). The purpose of the CST telephone contacts is to record the study data, and this will be occur for both study arms. Throughout the study, the patients in the telecardiology study arm will have regular contact with the Cordiva nurses for the management of their chronic heart failure, through telemonitoring and coaching. There is no planned hospitalization for the study. Patients in the control group will receive the usual care: After enrolment, they will return home and will subsequently have regular visits to their General Practitioner (GP) or referring cardiologist. Patients in the telecardiology group will receive the necessary monitoring equipment in their home in the week following their enrolment visit. This equipment includes a connected electronic scale and a questionnaire box. This questionnaire is designed to evaluate the evolution of patient symptoms. During the presentation of the study to the patient before study inclusion, the investigator will inform the patient about the use of the equipment. The material provided is self installable but if the patient asks for help, the equipment will be installed at the patient's home by a private nurse, who also will check that the patient knows how to use the equipment. Each patient will respond daily to 8 yes/no questions: * Did you have more breathing issues last night than the previous night? * Did you need an extra pillow for better breathing last night? * Do you cough more than usual? * Are your legs are more swollen than usual? * Do you feel yourself more tired than usual? * Have you had or do you have a fever above 38.5 °C? * Have you felt or do you feel palpitations? * Do you find that your physical activity is more limited today than the previous days? Patients should simply answer yes or no to all of these questions through the questionnaire box. The self-monitoring parameters (weight and questionnaire answers) will be remotely transmitted via standard phone lines (wired, 3G or GPRS) to the secured servers. These data will be analyzed automatically by an expert system that will generate an alert in case of abnormal values. The objective is to anticipate possible acute cardiac failure. The specialized nurses from the Cordiva center will manage those alerts during working hours and will contact the patient to validate with him the relevance of the alert. If the clinical reality of the alert is confirmed, the nurse will advise the patient to contact his GP or referring cardiologist. In parallel to the nurse advising the patient, the referring physician will receive an alert report including the weight values and the symptoms which triggered this alert. Then, he can then take any action he considers appropriate. A binder will be sent to the patients. This will contain various information related to the management of their heart failure: heart physiology, symptoms, treatments, diet, physical activity... The purpose of this binder is to support the discussion between the Cordiva nurses and the patient. Upon receipt and installation of the equipment in the patient's home, the nurses will arrange a first telephone interview, which will last approximately 45 minutes. The nurses will first introduce the team and the overall clinical approach, and will have a discussion with the patient to better understand the patient (anamnesis, treatment, psycho-social profile, smoking, alcohol use, physical activity, and so on). After this call, patient and nurse will together determine together the date for the next phone call date. On a regular basis (for example every three weeks), a Cordiva nurse will call the patient to check the current status of his disease and its treatment, and to assist him in the management of his disease on a daily basis (compliance, physical activity, nutrition, illness experience... ) . This call will last approx. 15 minutes, however, the duration of the call is not limited, but is defined according to the needs of the patient. At the end of each call, the nurse will define with the patient educational goals (disease knowledge, treatments, recognizing acute episodes symptoms, learning better health habits, practise regular physical activity). Cordiva center is also available for patient's inbound calls. In this way, patients will be able to easily call the center during working hours, and discuss with a specialized Cordiva nurse. This line is not an emergency line and does not replace the 112, which remains the only accredited contact in case of emergencies. In case of temporary travel of the patient away from home (i.e. for holidays), the patient can take the box and scale with him. This material is provided with GPRS SIM card, so the connection will be maintained. The patient may also provide an alternative phone number for the calls with the nurses. The patient's GP will be involved in this outpatient care from the beginning of the study. Indeed, data collected through the connected boxes and scales will be displayed in dedicated reports sent to the GP. These reports will be transmitted every 2 months. These reports will also be sent to the referring cardiologist if requested. Moreover, in case of validated alerts, the referring physician will have access to a weight and symptoms report, allowing him to take any action he thinks appropriate. ABOUT CORDIVA CENTER: The center has a team of specialized and graduated nurses in heart failure management and in therapeutic education, due to the dedicated training they have received. Indeed, many studies in the multidisciplinary care of heart failure patients have demonstrated the key role of nurses, acting as bridge between patients and health professionals. The nurses take care of patient compliance based on the referring cardiologist or general practitioner instructions, and monitor patient clinical parameters (weight and symptoms). The nurses use a software based interviews guide. Patient objectives are defined based on information regarding certain factors (health status, clinical signs, drugs), and this information will be collected by the nurses into a computerized database. This information is requested in strict patient accompanying perspective and therefore do not appear in the study results. The two data sets (data collected by nurses for patient management on one hand, and data collected by CST for the study on another hand) will never be connected and only study data from CST will be used to assess study criteria. To evaluate patient knowledge and needs, the nurses use active listening (open questions, paraphrasing, empathy and positive reinforcement). These techniques help them to customize information and messages and reinforce personalized care. Cordiva center nurses benefit from specialized training in motivational interviewing. They have also received dedicated training in cardiology and heart failure, mental state of heart failure patients, communication and patient education. Coherence of this informative approach is guaranteed on one hand because of the tools available for the nurses (binder, interview guide), and on the other hand because of the center organization itself: monitoring of patients insured by team of nurses, weekly debrief of recorded calls… EXTENSION PERIOD: The extension period will be conducted on an open, non-comparative basis. The aim of the extension period is to allow patients who wish to do so to follow the telemonitoring program until its marketing, regardless of the randomization group on initial inclusion in the study.
Interventions
The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses. Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.
Sponsors
Study design
Eligibility
Inclusion criteria
* Aged 18 years or older * Men or women patient with heart failure having been hospitalized for cardiac decompensation during the last 12 months. * Patient with access to a wireline telephone service or GPRS network. * The patient is willing and able to sign an informed written consent * Patient is insured under the social security system
Exclusion criteria
* No available echocardiographic evaluation. * BNP lower than 100pg/ml or NT-proBNP lower than 300pg/ml * A prognosis of a life span of less than 12 months (apart from heart failure) * Dialysis patients * Heart transplant or cardiac assist devices * Patients involved in inotropic treatment * Patient doesn't have the necessary autonomy to use the equipment * Patient enrolled in another clinical trial * A pregnant or nursing woman, or patient of reproductive age who doesn't use contraceptives * Patients under tutorship, curatorship or judicial protection Inclusion Criteria in the extension period: Participation in the open extension period is only offered to patients who participated in the comparative period of the study, did not withdraw prematurely from the latter and gave their free informed written consent to participate to the extension period.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of All Causes Deaths and (Unplanned) Hospitalizations | 18 months | Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events) |
| Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients | 18 months | Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events) |
| Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients | 18 months | Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Unplanned Hospitalizations for Any Cause | 18 months | Number of unplanned hospitalizations for any cause (adjudicated events) |
| Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause | 18 months | Composite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events) |
| Number of Unplanned Hospitalizations for Heart Failure | 18 months | Number of unplanned hospitalizations for heart failure (adjudicated events) |
| Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients | 18 months | Number of unplanned hospitalizations for heart failure (adjudicated events) |
| Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients | 18 months | Number of unplanned hospitalizations for heart failure (adjudicated events) |
| Time to First Unplanned Hospital Readmission or Death From Any Cause | 18 months | Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned |
| Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Between baseline and 12 months and between baseline and 18 months | Evolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health. |
| Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period | Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months) | Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period |
| Number of Patients Who Died From Any Cause During the Extension Period | Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months) | Number of patients who died from any cause during the extension period |
| Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period | Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months) | Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period |
| Number of Patients Who Died From Cardiovascular Cause During the Extension Period | Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months) | Number of patients who died from cardiovascular cause according to investigators during the extension period |
| Time to First Unplanned Hospital Readmission for Heart Failure | 18 months | Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned |
| All Causes Deaths - Number of Patients Who Died From Any Cause | 18 months | Number of patients who died from any cause |
| Time to Death From Any Cause | 18 months | Time to death from any cause in the subgroup of patients who died |
Countries
France, Martinique
Participant flow
Recruitment details
Between May 13, 2013 and June 22, 2016, 990 patients were enrolled at 38 French centers. Last patient completed 18-month comparative period on December 20, 2017. After this 18-month period, 20 patients entered the non-comparative extension period between June 1, 2017 and March 27, 2018. Last patient completed extension period on September 28, 2018.
Participants by arm
| Arm | Count |
|---|---|
| Standard Care Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists | 455 |
| Tele-cardiology Group The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure. | 482 |
| Total | 937 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| 18-month Comparative Study Period | Alzheimer's disease | 0 | 1 |
| 18-month Comparative Study Period | Death | 90 | 97 |
| 18-month Comparative Study Period | Hearing loss | 0 | 1 |
| 18-month Comparative Study Period | Heart transplant | 9 | 15 |
| 18-month Comparative Study Period | Hemiplegia | 0 | 1 |
| 18-month Comparative Study Period | Inclusion in another protocol | 0 | 2 |
| 18-month Comparative Study Period | Lost to Follow-up | 6 | 7 |
| 18-month Comparative Study Period | Move | 0 | 1 |
| 18-month Comparative Study Period | Withdrawal by Subject | 23 | 52 |
| Extension Period | Death | 0 | 2 |
| Extension Period | Heart transplant | 1 | 0 |
| Extension Period | Withdrawal by Subject | 1 | 0 |
| Extension Period | Wrong device use | 0 | 1 |
Baseline characteristics
| Characteristic | Total | Standard Care | Tele-cardiology Group |
|---|---|---|---|
| ACE inhibitors or ARBs No | 238 Participants | 110 Participants | 128 Participants |
| ACE inhibitors or ARBs Yes | 699 Participants | 345 Participants | 354 Participants |
| Age, Continuous | 69.9 years STANDARD_DEVIATION 12.4 | 69.7 years STANDARD_DEVIATION 12.5 | 70.0 years STANDARD_DEVIATION 12.4 |
| Age, Customized ≥ 60 and < 80 years | 505 Participants | 237 Participants | 268 Participants |
| Age, Customized < 60 years | 198 Participants | 105 Participants | 93 Participants |
| Age, Customized ≥ 80 years | 234 Participants | 113 Participants | 121 Participants |
| Aldosterone antagonists No | 506 Participants | 244 Participants | 262 Participants |
| Aldosterone antagonists Yes | 431 Participants | 211 Participants | 220 Participants |
| Arterial hypertension No | 395 Participants | 209 Participants | 186 Participants |
| Arterial hypertension Yes | 542 Participants | 246 Participants | 296 Participants |
| Beta-blockers No | 191 Participants | 88 Participants | 103 Participants |
| Beta-blockers Yes | 746 Participants | 367 Participants | 379 Participants |
| BNP | 501 pg/mL | 484 pg/mL | 510 pg/mL |
| Body Mass Index (BMI) | 27.4 kg/m² STANDARD_DEVIATION 5.8 | 27.1 kg/m² STANDARD_DEVIATION 5.5 | 27.6 kg/m² STANDARD_DEVIATION 6 |
| Cardiac resynchronization therapy No | 936 Participants | 454 Participants | 482 Participants |
| Cardiac resynchronization therapy Yes | 1 Participants | 1 Participants | 0 Participants |
| Cardiopathy Ischemic | 443 Participants | 211 Participants | 232 Participants |
| Cardiopathy Non Ischemic | 492 Participants | 243 Participants | 249 Participants |
| Chronic Obstructive Pulmonary Disease No | 759 Participants | 366 Participants | 393 Participants |
| Chronic Obstructive Pulmonary Disease Yes | 178 Participants | 89 Participants | 89 Participants |
| Chronic renal disease No | 679 Participants | 327 Participants | 352 Participants |
| Chronic renal disease Yes | 257 Participants | 128 Participants | 129 Participants |
| Coronary heart disease No | 473 Participants | 227 Participants | 246 Participants |
| Coronary heart disease Yes | 464 Participants | 228 Participants | 236 Participants |
| Diabetes mellitus No | 630 Participants | 294 Participants | 336 Participants |
| Diabetes mellitus Yes | 307 Participants | 161 Participants | 146 Participants |
| Digoxin No | 892 Participants | 439 Participants | 453 Participants |
| Digoxin Yes | 43 Participants | 15 Participants | 28 Participants |
| Dyslipidemia No | 420 Participants | 207 Participants | 213 Participants |
| Dyslipidemia Yes | 517 Participants | 248 Participants | 269 Participants |
| Family History of Cardiovascular Disease No | 755 Participants | 382 Participants | 373 Participants |
| Family History of Cardiovascular Disease Yes | 182 Participants | 73 Participants | 109 Participants |
| Glomerular Filtration Rate (GFR) | 60.5 mL/min STANDARD_DEVIATION 25.3 | 60.6 mL/min STANDARD_DEVIATION 25.1 | 60.5 mL/min STANDARD_DEVIATION 25.5 |
| Heart failure Global | 506 Participants | 235 Participants | 271 Participants |
| Heart failure Left | 369 Participants | 184 Participants | 185 Participants |
| Heart failure Right | 58 Participants | 34 Participants | 24 Participants |
| Implantable cardioverter-defibrillator No | 817 Participants | 395 Participants | 422 Participants |
| Implantable cardioverter-defibrillator Yes | 120 Participants | 60 Participants | 60 Participants |
| Ivabradine No | 872 Participants | 416 Participants | 456 Participants |
| Ivabradine Yes | 60 Participants | 37 Participants | 23 Participants |
| Left Ventricular Ejection Fraction (LVEF) | 38.7 Percentage STANDARD_DEVIATION 14.9 | 38.1 Percentage STANDARD_DEVIATION 15.2 | 39.3 Percentage STANDARD_DEVIATION 14.5 |
| Left Ventricular Ejection Fraction (LVEF), categorical ≤ 40% | 560 Participants | 280 Participants | 280 Participants |
| Left Ventricular Ejection Fraction (LVEF), categorical > 40% and ≤ 50% | 184 Participants | 89 Participants | 95 Participants |
| Left Ventricular Ejection Fraction (LVEF), categorical > 50% | 190 Participants | 86 Participants | 104 Participants |
| Loop diuretics No | 73 Participants | 38 Participants | 35 Participants |
| Loop diuretics Yes | 864 Participants | 417 Participants | 447 Participants |
| NT-pro-BNP | 3379 pg/mL | 3277 pg/mL | 3519 pg/mL |
| NYHA classification I | 61 Participants | 32 Participants | 29 Participants |
| NYHA classification II | 406 Participants | 196 Participants | 210 Participants |
| NYHA classification III | 367 Participants | 185 Participants | 182 Participants |
| NYHA classification IV | 93 Participants | 39 Participants | 54 Participants |
| Obesity No | 675 Participants | 333 Participants | 342 Participants |
| Obesity Yes | 262 Participants | 122 Participants | 140 Participants |
| Previous participation in an ETP No | 714 Participants | 341 Participants | 373 Participants |
| Previous participation in an ETP Yes | 223 Participants | 114 Participants | 109 Participants |
| Race and Ethnicity Not Collected | 0 Participants | — | — |
| Region of Enrollment France | 937 Participants | 455 Participants | 482 Participants |
| Sex: Female, Male Female | 260 Participants | 132 Participants | 128 Participants |
| Sex: Female, Male Male | 677 Participants | 323 Participants | 354 Participants |
| Smoking No | 710 Participants | 339 Participants | 371 Participants |
| Smoking Yes | 227 Participants | 116 Participants | 111 Participants |
| Supine diastolic blood pressure | 69.7 mmHg STANDARD_DEVIATION 11.7 | 69.5 mmHg STANDARD_DEVIATION 12.2 | 69.9 mmHg STANDARD_DEVIATION 11.2 |
| Supine pulse rate | 73.2 beats/min STANDARD_DEVIATION 14.7 | 72.7 beats/min STANDARD_DEVIATION 13.9 | 73.7 beats/min STANDARD_DEVIATION 15.4 |
| Supine systolic blood pressure | 119.3 mmHg STANDARD_DEVIATION 19.6 | 118.9 mmHg STANDARD_DEVIATION 19.3 | 119.6 mmHg STANDARD_DEVIATION 19.9 |
| Weight | 78.3 kg STANDARD_DEVIATION 18 | 77.2 kg STANDARD_DEVIATION 17.8 | 79.3 kg STANDARD_DEVIATION 18.2 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 90 / 455 | 99 / 482 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Number of All Causes Deaths and (Unplanned) Hospitalizations
Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of All Causes Deaths and (Unplanned) Hospitalizations | 1.46 Events | Standard Deviation 1.98 |
| Tele-cardiology Group | Number of All Causes Deaths and (Unplanned) Hospitalizations | 1.30 Events | Standard Deviation 1.85 |
Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients
Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)
Time frame: 18 months
Population: ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients | 1.99 Events | Standard Deviation 2.26 |
| Tele-cardiology Group | Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients | 1.53 Events | Standard Deviation 1.98 |
Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients
Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)
Time frame: 18 months
Population: ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients | 1.89 Events | Standard Deviation 2.14 |
| Tele-cardiology Group | Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients | 1.30 Events | Standard Deviation 1.66 |
All Causes Deaths - Number of Patients Who Died From Any Cause
Number of patients who died from any cause
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Standard Care | All Causes Deaths - Number of Patients Who Died From Any Cause | 89 Participants |
| Tele-cardiology Group | All Causes Deaths - Number of Patients Who Died From Any Cause | 91 Participants |
Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period
Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period
Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)
Population: Extension Period Set
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period | 1.30 Events | Standard Deviation 0.57 |
| Tele-cardiology Group | Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period | 3.30 Events | Standard Deviation 2.09 |
Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period
Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period
Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)
Population: Extension Period Set
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period | 1.30 Events | Standard Deviation 0.57 |
| Tele-cardiology Group | Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period | 2.84 Events | Standard Deviation 1.18 |
Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores
Evolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health.
Time frame: Between baseline and 12 months and between baseline and 18 months
Population: ITT population
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Component Summary - 18 Months | 2.0 score on a scale | Standard Deviation 10.4 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | General Health - 18 Months | 5.2 score on a scale | Standard Deviation 20.4 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Vitality - 12 Months | 5.7 score on a scale | Standard Deviation 22.1 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Vitality - 18 Months | 7.3 score on a scale | Standard Deviation 21.7 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Emotional - 12 Months | -4.3 score on a scale | Standard Deviation 45.7 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Emotional - 18 Months | 6.0 score on a scale | Standard Deviation 35.8 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Functioning - 12 months | -1.3 score on a scale | Standard Deviation 27.3 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Functioning - 18 months | 2.4 score on a scale | Standard Deviation 26.3 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Physical - 12 Months | 12.5 score on a scale | Standard Deviation 48 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Physical - 18 Months | 20.5 score on a scale | Standard Deviation 40.2 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Social Functioning - 18 Months | 3.2 score on a scale | Standard Deviation 33.3 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Bodily Pain - 18 Months | 0.6 score on a scale | Standard Deviation 35.8 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Bodily Pain - 12 Months | 1.9 score on a scale | Standard Deviation 38.8 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | General Health - 12 Months | 0.4 score on a scale | Standard Deviation 21.7 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Health - 18 Months | 3.3 score on a scale | Standard Deviation 18.9 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Health - 12 Months | 1.6 score on a scale | Standard Deviation 19.4 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Component Summary - 12 Months | 1.5 score on a scale | Standard Deviation 11.2 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Component Summary - 18 Months | 2.9 score on a scale | Standard Deviation 10.6 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Component Summary - 12 Months | 0.1 score on a scale | Standard Deviation 10.8 |
| Standard Care | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Social Functioning - 12 Months | -0.3 score on a scale | Standard Deviation 35.5 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Health - 18 Months | 4.3 score on a scale | Standard Deviation 18.5 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Social Functioning - 12 Months | 4.4 score on a scale | Standard Deviation 33.8 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Component Summary - 18 Months | 3.1 score on a scale | Standard Deviation 10.4 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Social Functioning - 18 Months | 3.8 score on a scale | Standard Deviation 33.9 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Vitality - 12 Months | 9.0 score on a scale | Standard Deviation 23.7 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Bodily Pain - 18 Months | 4.6 score on a scale | Standard Deviation 33.6 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Vitality - 18 Months | 11.1 score on a scale | Standard Deviation 21.8 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Component Summary - 12 Months | 2.2 score on a scale | Standard Deviation 11.1 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Emotional - 12 Months | -2.7 score on a scale | Standard Deviation 46.9 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | General Health - 12 Months | 3.4 score on a scale | Standard Deviation 22.3 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | General Health - 18 Months | 6.8 score on a scale | Standard Deviation 22.5 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Functioning - 12 months | 0.0 score on a scale | Standard Deviation 28 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Component Summary - 12 Months | 1.8 score on a scale | Standard Deviation 11.3 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Functioning - 18 months | 1.3 score on a scale | Standard Deviation 28.3 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Emotional - 18 Months | 8.3 score on a scale | Standard Deviation 35.9 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Physical Component Summary - 18 Months | 3.2 score on a scale | Standard Deviation 10.7 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Physical - 12 Months | 12.5 score on a scale | Standard Deviation 48 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Role Physical - 18 Months | 20.7 score on a scale | Standard Deviation 41.1 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Mental Health - 12 Months | 3.9 score on a scale | Standard Deviation 18.8 |
| Tele-cardiology Group | Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores | Bodily Pain - 12 Months | 4.1 score on a scale | Standard Deviation 36.9 |
Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause
Composite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events)
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause | 1.07 Events | Standard Deviation 1.75 |
| Tele-cardiology Group | Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause | 0.96 Events | Standard Deviation 1.56 |
Number of Patients Who Died From Any Cause During the Extension Period
Number of patients who died from any cause during the extension period
Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)
Population: Extension Period Set
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Standard Care | Number of Patients Who Died From Any Cause During the Extension Period | 0 Participants |
| Tele-cardiology Group | Number of Patients Who Died From Any Cause During the Extension Period | 2 Participants |
Number of Patients Who Died From Cardiovascular Cause During the Extension Period
Number of patients who died from cardiovascular cause according to investigators during the extension period
Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)
Population: Extension Period Set
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Standard Care | Number of Patients Who Died From Cardiovascular Cause During the Extension Period | 0 Participants |
| Tele-cardiology Group | Number of Patients Who Died From Cardiovascular Cause During the Extension Period | 0 Participants |
Number of Unplanned Hospitalizations for Any Cause
Number of unplanned hospitalizations for any cause (adjudicated events)
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of Unplanned Hospitalizations for Any Cause | 1.27 Events | Standard Deviation 1.82 |
| Tele-cardiology Group | Number of Unplanned Hospitalizations for Any Cause | 1.11 Events | Standard Deviation 1.67 |
Number of Unplanned Hospitalizations for Heart Failure
Number of unplanned hospitalizations for heart failure (adjudicated events)
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of Unplanned Hospitalizations for Heart Failure | 0.75 Events | Standard Deviation 1.42 |
| Tele-cardiology Group | Number of Unplanned Hospitalizations for Heart Failure | 0.59 Events | Standard Deviation 1.26 |
Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients
Number of unplanned hospitalizations for heart failure (adjudicated events)
Time frame: 18 months
Population: ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients | 1.02 Events | Standard Deviation 1.68 |
| Tele-cardiology Group | Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients | 0.70 Events | Standard Deviation 1.36 |
Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients
Number of unplanned hospitalizations for heart failure (adjudicated events)
Time frame: 18 months
Population: ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Standard Care | Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients | 1.00 Events | Standard Deviation 1.61 |
| Tele-cardiology Group | Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients | 0.58 Events | Standard Deviation 1.15 |
Time to Death From Any Cause
Time to death from any cause in the subgroup of patients who died
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to Death From Any Cause | 233 days |
| Tele-cardiology Group | Time to Death From Any Cause | 252 days |
Time to First Unplanned Hospital Readmission for Heart Failure
Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to First Unplanned Hospital Readmission for Heart Failure | 79 days |
| Tele-cardiology Group | Time to First Unplanned Hospital Readmission for Heart Failure | 97 days |
Time to First Unplanned Hospital Readmission or Death From Any Cause
Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned
Time frame: 18 months
Population: ITT population
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to First Unplanned Hospital Readmission or Death From Any Cause | 84 days |
| Tele-cardiology Group | Time to First Unplanned Hospital Readmission or Death From Any Cause | 105 days |
Time to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients
Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned
Time frame: 18 months
Population: New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients | 62 days |
| Tele-cardiology Group | Time to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients | 82 days |
Time to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients
Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned
Time frame: 18 months
Population: Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed'
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients | 77 days |
| Tele-cardiology Group | Time to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients | 80 days |
Time to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients
Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned
Time frame: 18 months
Population: New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients | 67 days |
| Tele-cardiology Group | Time to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients | 82 days |
Time to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients
Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned
Time frame: 18 months
Population: Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed'
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Standard Care | Time to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients | 81 days |
| Tele-cardiology Group | Time to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients | 91 days |